Genetic basis of Sjögren's syndrome. How strong is the evidence?

Clinical and Developmental Immunology

Volumn 13, Issue 2-4, 2006, Pages 209-222

  Anaya, Juan Manuel ^a,b   Delgado Vega, Angélica María ^a,b   Castiblanco, John ^a  

^a Unidad de Biología Celular y Molecular   (Colombia)

^b UNIVERSIDAD DEL ROSARIO   (Colombia)

Author keywords

CHRM3; IL10; Major histocompatibility complex; Sj gren's syndrome; SSA1

Indexed keywords

CHEMOKINE RECEPTOR CCR5; CYTOTOXIC T LYMPHOCYTE ANTIGEN 4; FAS ANTIGEN; GAMMA INTERFERON; GELATINASE B; HLA ANTIGEN CLASS 2; HLA DQ ANTIGEN; HLA DQA1 ANTIGEN; HLA DQB1 ANTIGEN; HLA DR ANTIGEN; INTERLEUKIN 10; INTERLEUKIN 6; LA ANTIBODY; PROTEIN TYROSINE PHOSPHATASE; RO ANTIBODY; TRANSFORMING GROWTH FACTOR BETA1; TRANSPORTER ASSOCIATED WITH ANTIGEN PROCESSING 1; TUMOR NECROSIS FACTOR;

ARTICLE; AUTOIMMUNE DISEASE; AUTOIMMUNE THYROIDITIS; ENVIRONMENTAL FACTOR; GENDER; GENE LINKAGE DISEQUILIBRIUM; GENETIC POLYMORPHISM; HAPLOTYPE; HEREDITY; HUMAN; INSULIN DEPENDENT DIABETES MELLITUS; LINKAGE ANALYSIS; MAJOR HISTOCOMPATIBILITY COMPLEX; ONSET AGE; PREVALENCE; PRIORITY JOURNAL; RHEUMATOID ARTHRITIS; SIBLING; SJOEGREN SYNDROME; SYSTEMIC LUPUS ERYTHEMATOSUS; TWINS;

GENETIC PREDISPOSITION TO DISEASE; HISTOCOMPATIBILITY ANTIGENS CLASS II; HLA ANTIGENS; HUMANS; SJOGREN'S SYNDROME;

EID: 33845601536     PISSN: 17402522     EISSN: 10292357     Source Type: Journal    
DOI: 10.1080/17402520600876911     Document Type: Article

References (130)

1. Ackerman LS. 2006. Sex hormones and the genesis of autoimmunity. Arch Dermatol 142:371-376.
2. Aittoniemi J, Miettinen A, Laippala P, Isolauri E, Viikari J, Ruuska T, Soppi E. 1996. Age-dependent variation in the serum concentration of mannan-binding protein. Acta Paediatr 85:906-909.
3. Alkhateeb A, Fain PR, Thody A, Bennett DC, Spritz RA. 2003. Epidemiology of vitiligo and associated autoimmune diseases in Caucasian probands and their families. Pigment Cell Res 16:208-214.
4. Altshuler D, Daly M, Kruglyak L. 2000. Guilt by association. Nat Genet 26:135-137.
5. Anaya JM, Liu GT, D'Souza E, Ogawa N, Luan X, Talal N. 1995a. Primary Sjogren's syndrome in men. Ann Rheum Dis 54:748-751.
6. Anaya JM, Ogawa N, Talal N. 1995b. Sjogren's syndrome in childhood. J Rheumatol 22:1152-1158.
7. Anaya JM, Talal N. 1997. Sjogren's syndrome and conective tissue diseases associated with immunologic disorders. In: Koopman W, editor. Athritis and allied conditions. 13th ed. Philadelphia: William & Wilkins. p 1561-1580.
8. Anaya JM, Correa PA, Mantilla RD. 1999. Síndrome de Sjögren primario. Características clínicas e inmunogenéticas. Acta Med Col :125-137.
9. Anaya JM, Ramos M, García M. 2001. Síndrome de Sjögren. Medellin: Corporación para Investigaciones Biológicas.
10. Anaya JM, Correa PA, Herrera M, Eskdale J, Gallagher G. 2002a. Interleukin 10 (IL-10) influences autoimmune response in primary Sjogren's syndrome and is linked to IL-10 gene polymorphism. J Rheumatol 29:1874-1876.
11. Anaya JM, Correa PA, Mantilla RD, Arcos-Burgos M. 2002b. TAP, HLA-DQB1, and HLA-DRB1 polymorphism in Colombian patients with primary Sjogren's syndrome. Semin Arthritis Rheum 31:396-405.
12. Anaya JM, Rivera D, Palacio LG, Arcos-Burgos M, Correa PA. 2003. D6S439 microsatellite identifies a new susceptibility region for primary Sjogren's syndrome. J Rheumatol 30:2152-2156.
13. Anaya JM, Mantilla RD, Correa PA. 2005a. Immunogenetics of primary Sjogren's syndrome in Colombians. Semin Arthritis Rheum 34:735-743.
14. Anaya JM, Shoenfeld Y, Correa PA, Garcia-Carrasco M, Cervera R. 2005b. Autoimmunity and autoimmune disease. 1 ed. Medellin: CIB.
15. Anaya JM, Castiblanco J, Tobon GJ, Garcia J, Abad V, Cuervo H, Velasquez A, Angel ID, Vega P, Arango A. 2006a. Familial clustering of autoimmune diseases in patients with type 1 diabetes mellitus. J Autoimmun 26:208-214.
16. Anaya JM, Tobon GJ, Pineda-Tamayo R, Castiblanco J. 2006b. Autoimmune disease aggregation in families of patients with primary Sjögren's syndrome. J Rheumatol 33:2227-2234.
17. Arend WP. 2002. The balance between IL-1 and IL-1Ra in disease. Cytokine Growth Factor Rev 13:323-340.
18. Bachmann M, Hilker M, Grolz D, Tellmann G, Hake U, Kater L, de Wilde P, Troster H. 1996. Different La/SS-B mRNA isoforms are expressed in salivary gland tissue of patients with primary Sjogren's syndrome. J Autoimmun 9:757-766.
19. Besana C, Salmaggi C, Pellegrino C, Pierro L, Vergani S, Faravelli A, Rugarli C. 1991. Chronic bilateral dacryo-adenitis in identical twins: A possible incomplete form of Sjogren syndrome. Eur J Pediatr 150:652-655.
20. Bias WB, Reveille JD, Beaty TH, Meyers DA, Arnett FC. 1986. Evidence that autoimmunity in man is a mendelian dominant trait. Am J Hum Genet :584-602.
21. Block SR, Winfield JB, Lockshin MD, D'Angelo WA, Christian CL. 1975. Studies of twins with systemic lupus erythematosus. A review of the literature and presentation of 12 additional sets. Am J Med 59:533-552.
22. Bolstad AI, Haga HJ, Wassmuth R, Jonsson R. 2000a. Monozygotic twins with primary Sjogren's syndrome. J Rheumatol 27:2264-2266.
23. Bolstad AI, Wargelius A, Nakken B, Haga HJ, Jonsson R. 2000b. Fas and Fas ligand gene polymorphisms in primary Sjogren's syndrome. J Rheumatol 27:2397-2405.
24. Bolstad AI, Wassmuth R, Haga HJ, Jonsson R. 2001. HLA markers and clinical characteristics in Caucasians with primary Sjogren's syndrome. J Rheumatol 28:1554-1562.
25. Bowman SJ, Ibrahim GH, Holmes G, Hamburger J, Ainsworth JR. 2004. Estimating the prevalence among Caucasian women of primary Sjogren's syndrome in two general practices in Birmingham, UK. Scand J Rheumatol 33:39-43.
26. Broadley SA, Deans J, Sawcer SJ, Clayton D, Compston DA. 2000. Autoimmune disease in first-degree relatives of patients with multiple sclerosis. A UK survey. Brain 123(Pt 6):1102-1111.
27. Camargo JF, Correa PA, Castiblanco J, Anaya JM. 2004. Interleukin-1beta polymorphisms in Colombian patients with autoimmune rheumatic diseases. Genes Immun 5:609-614.
28. Caserta TM, Knisley AA, Tan FK, Arnett FC, Brown TL. 2004. Genotypic analysis of the TGF beta-509 allele in patients with systemic lupus erythematosus and Sjogren's syndrome. Ann Genet 47:359-363.
29. Cooper GS, Stroehla BC. 2003. The epidemiology of autoimmune diseases. Autoimmun Rev 2:119-125.
30. Correa PA, Gomez LM, Cadena J, Anaya JM. 2005a. Autoimmunity and tuberculosis. Opposite association with TNF polymorphism. J Rheumatol 32:219-224.
31. Correa PA, Sterin-Borda L, Borda E, Anaya JM. 2005b. Cholinergic M3 receptor gene polymorhism in primary Sjogren's syndrome. Ann Rheum Dis 64(Suppl 3):116.
32. Chitnis S, Monteiro J, Glass D, Apatoff B, Salmon J, Concannon P, Gregersen PK. 2000. The role of X-chromosome inactivation in female predisposition to autoimmunity. Arthritis Res 2:399-406.
33. Criswell LA, Pfeiffer KA, Lum RF, Gonzales B, Novitzke J, Kern M, Moser KL, Begovich AB, Carlton VE, Li W, et al. 2005. Analysis of families in the multiple autoimmune disease genetics consortium (MADGC) collection: The PTPN22 620W allele associates with multiple autoimmune phenotypes. Am J Hum Genet 76:561-571.
34. Daniels TE, Whitcher JP. 1994. Association of patterns of labial salivary gland inflammation with keratoconjunctivitis sicca. Analysis of 618 patients with suspected Sjogren's syndrome. Arthritis Rheum 37:869-877.
35. Davidson A, Diamond B. 2001. Autoimmune diseases. N Engl J Med 345:340-350.
36. Downie-Doyle S, Lester S, Bardy P, Gordon T, Rischmueller M, Pile K. 2002. Immunoglobulin kappa light chain gene alleles are not associated with primary Sjogren's syndrome. Genes Immun 1(3 Suppl):S63-S65.
37. Fenech AG, Ebejer MJ, Felice AE, Ellul-Micallef R, Hall IP. 2001. Mutation screening of the muscarinic M(2) and M(3) receptor genes in normal and asthmatic subjects. Br J Pharmacol 133:43-48.
38. Firooz A, Mazhar A, Ahmed AR. 1994. Prevalence of autoimmune diseases in the family members of patients with pemphigus vulgaris. J Am Acad Dermatol 31:434-437.
39. Font J, Garcia-Carrasco M, Ramos-Casals M, Aldea AI, Cervera R, Ingelmo M, Vives J, Yague J. 2002. The role of interleukin-10 promoter polymorphisms in the clinical expression of primary Sjogren's syndrome. Rheumatology (Oxford) 41:1025-1030.
40. Forsythe SM, Kogut PC, McConville JF, Fu Y, McCauley JA, Halayko AJ, Liu HW, Kao A, Fernandes DJ, Bellam S, et al. 2002. Structure and transcription of the human m3 muscarinic receptor gene. Am J Respir Cell Mol Biol 26:298-305.
41. Foster H, Fay A, Kelly C, Charles P, Walker D, Griffiths I. 1993a. Thyroid disease and other autoimmune phenomena in a family study of primary Sjogren's syndrome. Br J Rheumatol 32:36-40.
42. Foster H, Stephenson A, Walker D, Cavanagh G, Kelly C, Griffiths I. 1993b. Linkage studies of HLA and primary Sjogren's syndrome in multicase families. Arthritis Rheum 36:473-484.
43. Fox RI, Bumol T, Fantozzi R, Bone R, Schreiber R. 1986. Expression of histocompatibility antigen HLA-DR by salivary gland epithelial cells in Sjogren's syndrome. Arthritis Rheum 29:1105-1111.
44. Fox RI, Kang HI, Ando D, Abrams J, Pisa E. 1994. Cytokine mRNA expression in salivary gland biopsies of Sjogren's syndrome. J Immunol 152:5532-5539.
45. Frank MB, Itoh K, Fujisaku A, Pontarotti P, Mattei MG, Neas BR. 1993. The mapping of the human 52-kD Ro/SSA autoantigen gene to human chromosome 11, and its polymorphisms. Am J Hum Genet 52:183-191.
46. Frank MB, Mattei MG. 1994. Mapping of the human 60,000 M(r) Ro/SSA locus: The genes for three Ro/SSA autoantigens are located on separate chromosomes. Immunogenetics 39:428-431.
47. Gabriel SB, Schaffner SF, Nguyen H, Moore JM, Roy J, Blumenstiel B, Higgins J, DeFelice M, Lochner A, Faggart M, et al. 2002. The structure of haplotype blocks in the human genome. Science 296:2225-2229.
48. Ginn LR, Lin JP, Plotz PH, Bale SJ, Wilder RL, Mbauya A, Miller FW. 1998. Familial autoimmunity in pedigrees of idiopathic inflammatory myopathy patients suggests common genetic risk factors for many autoimmune diseases. Arthritis Rheum 41:400-405.
49. Goldblatt F, Gordon TP, Waterman SA. 2002. Antibody-mediated gastrointestinal dysmotility in scleroderma. Gastroenterology 123:1144-1150.
50. Gomez LM, Anaya JM, Gonzalez CI, Pineda-Tamayo R, Otero W, Arango A, Martin J. 2005. PTPN22 C1858T polymorphism in Colombian patients with autoimmune diseases. Genes Immun 6:628-631.
51. Gottenberg JE, Busson M, Loiseau P, Cohen-Solal J, Lepage V, Charron D, Sibilia J, Mariette X. 2003. In primary Sjogren's syndrome, HLA class II is associated exclusively with autoantibody production and spreading of the autoimmune response. Arthritis Rheum 48:2240-2245.
52. Gottenberg JE, Busson M, Loiseau P, Dourche M, Cohen-Solal J, Lepage V, Charron D, Miceli C, Sibilia J, Mariette X. 2004. Association of transforming growth factor beta1 and tumor necrosis factor alpha polymorphisms with anti-SSB/La antibody secretion in patients with primary Sjogren's syndrome. Arthritis Rheum 50:570-580.
53. Gregersen PK, Silver J, Winchester RJ. 1987. The shared epitope hypothesis. An approach to understanding the molecular genetics of susceptibility to rheumatoid arthritis. Arthritis Rheum 30:1205-1213.
54. Guggenbuhl P, Veillard E, Quelvenec E, Jego P, Semana G, Jean S, Meadeb J, Chales G, Perdriger A. 2000. Analysis of TNFalpha microsatellites in 35 patients with primary Sjogren's syndrome. Joint Bone Spine 67:290-295.
55. Hadj Kacem H, Kaddour N, Adyel FZ, Bahloul Z, Ayadi H. 2001. HLA-DQB1 CAR1/CAR2, TNFa IR2/IR4 and CTLA-4 polymorphisms in Tunisian patients with rheumatoid arthritis and Sjogren's syndrome. Rheumatology (Oxford) 40:1370-1374.
56. Harangi M, Kaminski WE, Fleck M, Orso E, Zeher M, Kiss E, Szekanecz Z, Zilahi E, Marienhagen J, Aslanidis C, et al. 2005. Homozygosity for the 168His variant of the minor histocompatibility antigen HA-1 is associated with reduced risk of primary Sjogren's syndrome. Eur J Immunol 35:305-317.
57. Herberg JA, Phillips S, Beck S, Jones T, Sheer D, Wu JJ, Prochazka V, Barr PJ, Kiefer MC, Trowsdale J. 1998. Genomic structure and domain organisation of the human Bak gene. Gene 211:87-94.
58. Horton R, Wilming L, Rand V, Lovering RC, Bruford EA, Khodiyar VK, Lush MJ, Povey S, Talbot CC Jr, Wright MW, et al. 2004. Gene map of the extended human MHC. Nat Rev Genet 5:889-899.
59. Houghton KM, Cabral DA, Petty RE, Tucker LB. 2005. Primary Sjogren's syndrome in dizygotic adolescent twins: One case with lymphocytic interstitial pneumonia. J Rheumatol 32:1603-1606.
60. Hsu HC, Mountz JD. 2003. Origin of late-onset autoimmune disease. Immunol Allergy Clin North Am 23(vi):65-82.
61. Hulkkonen J, Pertovaara M, Antonen J, Lahdenpohja N, Pasternack A, Hurme M. 2001a. Genetic association between interleukin-10 promoter region polymorphisms and primary Sjogren's syndrome. Arthritis Rheum 44:176-179.
62. Hulkkonen J, Pertovaara M, Antonen J, Pasternack A, Hurme M. 2001b. Elevated interleukin-6 plasma levels are regulated by the promoter region polymorphism of the IL6 gene in primary Sjogren's syndrome and correlate with the clinical manifestations of the disease. Rheumatology (Oxford) 40:656-661.
63. Hulkkonen J, Pertovaara M, Antonen J, Pasternack A, Hurme M, Pollanen P, Lehtimaki T. 2004. Matrix metalloproteinase 9 (MMP-9) gene polymorphism and MMP-9 plasma levels in primary Sjogren's syndrome. Rheumatology (Oxford) 43:1476-1479.
64. Humphreys-Beher MG, Peck AB, Dang H, Talal N. 1999. The role of apoptosis in the initiation of the autoimmune response in Sjogren's syndrome. Clin Exp Immunol 116:383-387.
65. Imanishi T, Morinobu A, Hayashi N, Kanagawa S, Koshiba M, Kondo S, Kumagai S. 2005. A novel polymorphism of the SSA1 gene is associated with anti-SS-A/Ro52 autoantibody in Japanese patients with primary Sjogren's syndrome. Clin Exp Rheumatol 23:521-524.
66. Invernizzi P, Miozzo M, Selmi C, Persani L, Battezzati PM, Zuin M, Lucchi S, Meroni PL, Marasini B, Zeni S, et al. 2005. X chromosome monosomy: A common mechanism for autoimmune diseases. J Immunol 175:575-578.
67. Itoh K, Itoh Y, Frank MB. 1991. Protein heterogeneity in the human Ro/SSA ribonucleoproteins. The 52- and 60-kD Ro/SSA autoantigens are encoded by separate genes. J Clin Invest 87:177-186.
68. James JA, Harley JB, Scofield RH. 2001. Role of viruses in systemic lupus erythematosus and Sjogren syndrome. Curr Opin Rheumatol 13:370-376.
69. Jean S, Quelvennec E, Alizadeh M, Guggenbuhl P, Birebent B, Perdriger A, Grosbois B, Pawlotsky PY, Semana G. 1998. DRB1*15 and DRB1*03 extended haplotype interaction in primary Sjogren's syndrome genetic susceptibility. Clin Exp Rheumatol 16:725-728.
70. Kang HI, Fei HM, Saito I, Sawada S, Chen SL, Yi D, Chan E, Peebles C, Bugawan TL, Erlich HA, et al. 1993. Comparison of HLA class II genes in Caucasoid Chinese, and Japanese patients with primary Sjogren's syndrome. J Immunol 150:3615-3623.
71. Kast RE. 1977. Predominance of autoimmune and rheumatic diseases in females. J Rheumatol 4:288-292.
72. Kerttula TO, Collin P, Polvi A, Korpela M, Partanen J, Maki M. 1996. Distinct immunologic features of Finnish Sjogren's syndrome patients with HLA alleles DRB1*0301, DQA1*0501, and DQB1*0201. Alterations in circulating T cell receptor gamma/delta subsets. Arthritis Rheum 39:1733-1739.
73. Koski H, Konttinen YT, Gu XH, Hietanen J, Malmstrom M. 1995. Transforming growth factor beta 2 in labial salivary glands in Sjogren's syndrome. Ann Rheum Dis 54:744-747.
74. Kumagai S, Kanagawa S, Morinobu A, Takada M, Nakamura K, Sugai S, Maruya E, Saji H. 1997. Association of a new allele of the TAP2 gene, TAP2*Bky2 (Val577), with susceptibility to Sjogren's syndrome. Arthritis Rheum 40:1685-1692.
75. Limaye V, Lester S, Downie-Doyle S, Pile K, Bardy P, Gordon TP, Rischmueller M. 2000. Polymorphisms of the interleukin 10 gene promoter are not associated with anti-Ro autoantibodies in primary Sjogren's syndrome. J Rheumatol 27:2945-2946.
76. Lin JP, Cash JM, Doyle SZ, Peden S, Kanik K, Amos CI, Bale SJ, Wilder RL. 1998. Familial clustering of rheumatoid arthritis with other autoimmune diseases. Hum Genet 103:475-482.
77. Lockshin MD. 2002. Sex ratio and rheumatic disease. Autoimmun Rev 1:162-167.
78. Louis E, Franchimont D, Piron A, Gevaert Y, Schaaf-Lafontaine N, Roland S, Mahieu P, Malaise M, De Groote D, Louis R, Belaiche J. 1998. Tumour necrosis factor (TNF) gene polymorphism influences TNF-alpha production in lipopolysaccharide (LPS)-stimulated whole blood cell culture in healthy humans. Clin Exp Immunol 113:401-406.
79. Llorente L, Richaud-Patin Y, Fior R, Alcocer-Varela J, Wijdenes J, Fourrier BM, Galanaud P, Emilie D. 1994. In vivo production of interleukin-10 by non-T cells in rheumatoid arthritis. Sjogren's syndrome, and systemic lupus erythematosus. A potential mechanism of B lymphocyte hyperactivity and autoimmunity. Arthritis Rheum 37:1647-1655.
80. Magnusson V, Nakken B, Bolstad AI, Alarcon-Riquelme ME. 2001. Cytokine polymorphisms in systemic lupus erythematosus and Sjogren's syndrome. Scand J Immunol 54:55-61.
81. Merkler D, Horvath E, Bruck W, Zinkernagel RM, Del la Torre JC, Pinschewer DD. 2006. "Viral deja vu" elicits organ-specific immune disease independent of reactivity to self. J Clin Invest 116:1254-1263.
82. Michel M, Johanet C, Meyer O, Frances C, Wittke F, Michel C, Arfi S, Tournier-Lasserve E, Piette JC. 2001. Familial lupus erythematosus. Clinical and immunologic features of 125 multiplex families. Medicine (Baltimore) 80:153-158.
83. Mitsias DI, Kapsogeorgou EK, Moutsopoulos HM. 2006. The role of epithelial cells in the initiation and perpetuation of autoimmune lesions: Lessons from Sjögren's syndrome (autoimmune epithelitis). Lupus 15:255-261.
84. Miyagawa S, Shinohara K, Nakajima M, Kidoguchi K, Fujita T, Fukumoto T, Yoshioka A, Dohi K, Shirai T. 1998. Polymorphisms of HLA class II genes and autoimmune responses to Ro/SS-A-La/SS-B among Japanese subjects. Arthritis Rheum 41:927-934.
85. Molta CT, Khan MA, Aponte CJ, Reynolds TL, Macintyre SS. 1989. Familial occurrence of systemic sclerosis, rheumatoid arthritis and other immunological disorders: Report of two kindreds with study of HLA antigens and review of the literature. Clin Exp Rheumatol 7:229-236.
86. Mori M, Yamada R, Kobayashi K, Kawaida R, Yamamoto K. 2005. Ethnic differences in allele frequency of autoimmune-disease-associated SNPs. J Hum Genet 50:264-266.
87. Moutsopoulos HM. 1994. Sjogren's syndrome: Autoimmune epithelitis. Clin Immunol Immunopathol 72:162-165.
88. Muraki Y, Tsutsumi A, Takahashi R, Suzuki E, Hayashi T, Chino Y, Goto D, Matsumoto I, Murata H, Noguchi E, Sumida T. 2004. Polymorphisms of IL-1 beta gene in Japanese patients with Sjogren's syndrome and systemic lupus erythematosus. J Rheumatol 31:720-725.
89. Nakken B, Jonsson R, Bolstad AI. 2001. Polymorphisms of the Ro52 gene associated with anti-Ro 52-kd autoantibodies in patients with primary Sjogren's syndrome. Arthritis Rheum 44:638-646.
90. O'Brien CA, Wolin SL. 1994. A possible role for the 60-kD Ro autoantigen in a discard pathway for defective 5S rRNA precursors. Genes Dev 8:2891-2903.
91. Ohyama Y, Nakamura S, Matsuzaki G, Shinohara M, Hiroki A, Fujimura T, Yamada A, Itoh K, Nomoto K. 1996. Cytokine messenger RNA expression in the labial salivary glands of patients with Sjogren's syndrome. Arthritis Rheum 39:1376-1384.
92. Ostuni PA, Ianniello A, Sfriso P, Mazzola G, Andretta M, Gambari PF. 1996. Juvenile onset of primary Sjogren's syndrome: Report of 10 cases. Clin Exp Rheumatol 14:689-693.
93. Papasteriades CA, Skopouli FN, Drosos AA, Andonopoulos AP, Moutsopoulos HM. 1988. HLA-alloantigen associations in Greek patients with Sjogren's syndrome. J Autoimmun 1:85-90.
94. Pearce SH, Merriman TR. 2006. Genetic progress towards the molecular basis of autoimmunity. Trends Mol Med 12:90-98.
95. Perrier S, Coussediere C, Dubost JJ, Albuisson E, Sauvezie B. 1998. IL-1 receptor antagonist (IL-1RA) gene polymorphism in Sjogren's syndrome and rheumatoid arthritis. Clin Immunol Immunopathol 87:309-313.
96. Pertovaara M, Lehtimaki T, Rontu R, Antonen J, Pasternack A, Hurme M. 2004. Presence of apolipoprotein E epsilon4 allele predisposes to early onset of primary Sjogren's syndrome. Rheumatology (Oxford) 43:1484-1487.
97. Pertovaara M, Antonen J, Hurme M. 2006. Th2 cytokine genotypes are associated with a milder formof primary Sjogren's syndrome. Ann Rheum Dis 65:666-670.
98. Petrek M, Cermakova Z, Hutyrova B, Micekova D, Drabek J, Rovensky J, Bosak V. 2002. CC chemokine receptor 5 and interleukin-1 receptor antagonist gene polymorphisms in patients with primary Sjogren's syndrome. Clin Exp Rheumatol 20:701-703.
99. Plenge R, Rioux JD. 2006. Identifying susceptibility genes for immunological disorders: Patterns, power, and proof. Immunol Rev 210:40-51.
100. Prahalad S, Shear ES, Thompson SD, Giannini EH, Glass DN. 2002. Increased prevalence of familial autoimmunity in simplex and multiplex families with juvenile rheumatoid arthritis. Arthritis Rheum 46:1851-1856.
101. Price P, Witt C, Allcock R, Sayer D, Garlepp M, Kok CC, French M, Mallal S, Christiansen F. 1999. The genetic basis for the association of the 8.1 ancestral haplotype (A1, B8, DR3) with multiple immunopathological diseases. Immunol Rev 167:257-274.
102. Priori R, Medda E, Conti F, Cassara EA, Danieli MG, Gerli R, Giacomelli R, Franceschini F, Manfredi A, Pietrogrande M, et al. 2003. Familial autoimmunity as a risk factor for systemic lupus erythematosus and vice versa: A case-control study. Lupus 12:735-740.
103. Reveille JD, Bias WB, Winkelstein JA, Provost T, Dorsch CA, Arnett FC. 1983. Familial systemic lupus erythematosus: Immunogenetic studies in eight families. Medicine (Baltimore) 1:21-35.
104. Reveille JD, Wilson RW, Provost TT, Bias WB, Arnett FC. 1984. Primary Sjogren's syndrome and other autoimmune diseases in families. Prevalence and immunogenetic studies in six kindreds. Ann Intern Med 101:748-756.
105. Reveille JD, Macleod MJ, Whittington K, Arnett FC. 1991. Specific amino acid residues in the second hypervariable region of HLADQA1 and DQB1 chain genes promote the Ro (SS-A)/La (SSB) autoantibody responses. J Immunol 146:3871-3876.
106. Rischmueller M, Lester S, Chen Z, Champion G, Van Den Berg R, Beer R, Coates T, McCluskey J, Gordon T. 1998. HLA class II phenotype controls diversification of the autoantibody response in primary Sjogren's syndrome (pSS). Clin Exp Immunol 111:365-371.
107. Roitberg-Tambur A, Brautbar C, Markitziu A, Ben-Chetrit E, Rubinow A, Friedmann A. 1990. Immunogenetics of HLA class II genes in primary Sjogren's syndrome in Israeli Jewish patients. Isr J Med Sci 26:677-681.
108. Roitberg-Tambur A, Friedmann A, Safirman C, Markitziu A, Ben-Chetrit E, Rubinow A, Moutsopoulos HM, Stavropoulos E, Skopouli FN, Margalit H, et al. 1993. Molecular analysis of HLA class II genes in primary Sjogren's syndrome. A study of Israeli Jewish and Greek non-Jewish patients. Hum Immunol 36:235-242.
109. Rosen A, Casciola-Rosen L. 2004. Altered autoantigen structure in Sjogren's syndrome: Implications for the pathogenesis of autoimmune tissue damage. Crit Rev Oral Biol Med 15:156-164.
110. Saito I, Haruta K, Shimuta M, Inoue H, Sakurai H, Yamada K, Ishimaru N, Higashiyama H, Sumida T, Ishida H, et al. 1999. Fas ligand-mediated exocrinopathy resembling Sjogren's syndrome in mice transgenic for IL-10. J Immunol 162:2488-2494.
111. Simila S, Kokkonen J, Kaski M. 1978. Achalasia sicca - juvenile Sjogren's syndrome with achalasia and gastric hyposecretion. Eur J Pediatr 129:175-181.
112. Sloka S. 2002. Observations on recent studies showing increased cooccurrence of autoimmune diseases. J Autoimmun 18:251-257.
113. Steinfeld S, Maho A, Chaboteaux C, Daelemans P, Pochet R, Appelboom T, Kiss R. 2000. Prolactin up-regulates cathepsin B and D expression in minor salivary glands of patients with Sjogren's syndrome. Lab Invest 80:1711-1720.
114. Stern LJ, Brown JH, Jardetzky TS, Gorga JC, Urban RG, Strominger JL, Wiley DC. 1994. Crystal structure of the human class II MHC protein HLA-DR1 complexed with an influenza virus peptide. Nature 368:215-221.
115. Stewart JJ. 1999. Theory and treatment of the X-inactivation chimera in female-prevalent autoimmune disease. Arch Immunol Ther Exp (Warsz) 47:355-359.
116. Tait KF, Marshall T, Berman J, Carr-Smith J, Rowe B, Todd JA, Bain SC, Barnett AH, Gough SC. 2004. Clustering of autoimmune disease in parents of siblings from the type 1 diabetes Warren repository. Diabet Med 21:358-362.
117. Taiym S, Haghighat N, Al-Hashimi I. 2004. A comparison of the hormone levels in patients with Sjogren's syndrome and healthy controls. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 97:579-583.
118. Tan EM, Cohen AS, Fries JF, Masi AT, McShane DJ, Rothfield NF, Schaller JG, Talal N, Winchester RJ. 1982. The 1982 revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 25:1271-1277.
119. Thomas E, Hay EM, Hajeer A, Silman AJ. 1998. Sjogren's syndrome: A community-based study of prevalence and impact. Br J Rheumatol 37:1069-1076.
120. Tobon GJ, Correa PA, Gomez LM, Anaya JM. 2005. Lack of association between TNF-308 polymorphism and the clinical and immunological characteristics of systemic lupus erythematosus and primary Sjogren's syndrome. Clin Exp Rheumatol 23:339-344.
121. Tomer Y, Davies TF. 2003. Searching for the autoimmune thyroid disease susceptibility genes: From gene mapping to gene function. Endocr Rev 24:694-717.
122. Tsutsumi A, Sasaki K, Wakamiya N, Ichikawa K, Atsumi T, Ohtani K, Suzuki Y, Koike T, Sumida T. 2001. Mannose-binding lectin gene: Polymorphisms in Japanese patients with systemic lupus erythematosus, rheumatoid arthritis and Sjogren's syndrome. Genes Immun 2:99-104.
123. van Parijs L, Perez VL, Abbas AK. 1998. Mechanisms of peripheral T cell tolerance. Novartis Found Symp 215:5-14; discussion 14-20, 33-40.
124. Villarreal GM, Alcocer-Varela J, Llorente L. 1995. Cytokine gene and CD25 antigen expression by peripheral blood T cells from patients with primary Sjogren's syndrome. Autoimmunity 20:223-229.
125. Vitali C, Tavoni A, Rizzo G, Neri R, D'Ascanio A, Cristofani R, Bombardieri S. 1986. HLA antigens in Italian patients with primary Sjogren's syndrome. Ann Rheum Dis 45:412-416.
126. Vitali C, Bombardieri S, Jonsson R, Moutsopoulos HM, Alexander EL, Carsons SE, Daniels TE, Fox PC, Fox RI, Kassan SS, et al. 2002. Classification criteria for Sjogren's syndrome: A revised version of the European criteria proposed by the American-European Consensus Group. Ann Rheum Dis 61:554-558.
127. Wada K, Kamitani T. 2006. Autoantigen Ro52 is an E3 ubiquitin ligase. Biochem Biophys Res Commun 339:415-421.
128. Wandstrat A, Wakeland E. 2001. The genetics of complex autoimmune diseases: Non-MHC susceptibility genes. Nat Immunol 2:802-809.
129. Waterman SA, Gordon TP, Rischmueller M. 2000. Inhibitory effects of muscarinic receptor autoantibodies on parasympathetic neurotransmission in Sjogren's syndrome. Arthritis Rheum 43:1647-1654.
130. Wilson AG, de Vries N, Pociot F, de Giovine FS, van der Putte LB, Duff GW. 1993. An allelic polymorphism within the human tumor necrosis factor alpha promoter region is strongly associated with HLA A1, B8, and DR3 alleles. J Exp Med 177:557-560.